UK markets open in 4 hours 10 minutes
NIKKEI 225
38,527.60 -309.86 (-0.80%) HANG SENG
18,644.94 +200.83 (+1.09%) CRUDE OIL
73.26 +0.01 (+0.01%) GOLD FUTURES
2,352.00 +4.60 (+0.20%) DOW
38,711.29 +140.26 (+0.36%) Bitcoin GBP
55,481.51 +1,407.19 (+2.60%)
Prothena Corporation plc (0PT.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 09:50PM CEST
Loading interactive chart…
- Zacks
Prothena (PRTA), Bristol Myers Tie Up for Second Neuro Candidate
Prothena (PRTA) announces that Bristol Myers is exercising its option for the second time, thereby in-licensing exclusive global rights for PRX019 to potentially treat neurodegenerative diseases.
- Business Wire
Prothena Announces Bristol Myers Squibb Opt-in for Exclusive Global License for PRX019, the Second Program from Global Neuroscience Research and Development Collaboration
DUBLIN, May 28, 2024--Prothena today announced that Bristol Myers Squibb obtained the exclusive global license for PRX019 and will pay Prothena $80 million.
- Simply Wall St.
News Flash: Analysts Just Made A Notable Upgrade To Their Prothena Corporation plc (NASDAQ:PRTA) Forecasts
Celebrations may be in order for Prothena Corporation plc ( NASDAQ:PRTA ) shareholders, with the analysts delivering a...
© 2024 Yahoo. All rights reserved.